Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 5NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cytarabine 15Daunorubicin 9Gemtuzumab 7Filgrastim 6sargramostim 5Gene Expression Profiling 5Flow Cytometry 5Mitoxantrone 4Idarubicin 4Etoposide 4Peripheral Blood Stem Cell Transplantation 3Clofarabine 3Polymerase Chain Reaction 2Observation 2Immunologic Techniques 2Granulocyte Colony-Stimulating Factor 2DNA Methylation 2Asparaginase 2zosuquidar trihydrochloride 1valspodar 1fludarabine phosphate 1etoposide phosphate 1Topotecan 1Thiotepa 1Thioguanine 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Pharmacogenomic Testing 1Microarray Analysis 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Monocytic, Acute × Antilymphocyte Serum × Clear all
NCT00101140 2017-10-19

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡